Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population

Gut

Volumn 40, Issue 1, 1997, Pages 128-132

  Haydon, G H ^a   Jarvis, L M ^a   Simmonds, P ^a   Harrison, D J ^a   Garden, O J ^a   Hayes, P C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

HCV genotypes; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UNITED KINGDOM;

EID: 0031048232     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.1.128     Document Type: Article

References (37)

1. Moradpur D, Wands JR. The molecular pathogenesis of hepatocellular carcinoma. J Viral Hepat 1994; 1: 17-31.
2. Haydon GH, Hayes PC. Hepatocellular carcinoma. Br J Hosp Med 1995; 53: 74-80.
3. Blum HE. Does hepatitis C virus cause hepatocellular carcinoma? Hepatology 1994; 19: 251-5.
4. Columbo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, et al. Prevalence of antibodies of hepatitis C virus in Italian patients with Hepatocellular carcinoma. Lancet 1989; ii: 1006-8.
5. Simonetti RG, Cottone M, Craxi A, Pagliaro L, Rapicetta M, Chionne P, et al. Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet 1989; ii: 1338.
6. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma. Lancet 1989; ii: 1004-6.
7. Ruix J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj, Herrero JI, Prieto J. Hepatitis B and C viral infections in patients with Hepatocellular carcinoma. Hepatology 1992; 16: 637-41.
8. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, et al. Inter-relationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
9. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Acad Sci USA 1990; 87: 6547-9.
10. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in Southern African Blacks with hepatocellular carcinoma. Lancet 1990; 335: 873-4.
11. Bukh J, Miler RH, Kew MC, Purcell RH. Hepatitis C virus RNA in Southern African blacks with hepatocellular carcinoma. Proc Natl Acad Sci USA 1993; 90: 1848-51.
12. Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990; 162: 817-22.
13. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570-83.
14. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follet EAC, et al. Survey of major genotypes and subtypes of Hepatitis C virus using restriction fragment length polymorphism of sequences amplified from the 5′ Non-coding region. J Gen Virol 1995; 76: 1197.
15. McOmish F, Chan S, Dow BC, Gillon J, Frame W, Crawford R, et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serological reactivity and rate of alanine amino-transferase abnormalities. Transfusion 1993; 33: 7-13.
16. Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. Viral and host factors that contribute to efficacy of interferon-2a therapy in patients with chronic hepatitis C. Dig Dis Sci 1994; 39: 977-82.
17. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titre. Dig Dis Sci 1994; 39: 977-82.
18. Hanley JP, Jarvis LM, Andrews J, Dennis R, Hayes PC, Lee R, et al. Interferon treatment for chronic hepatitis C in haemophiliacs-Assessment of response using a semi-quantitative polymerase chain reaction method. Blood 1996; 87: 1704-9.
19. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P. Brechot C: and the collaborative Study Group. Hepatitis C virus genotype 1b infection in France and Italy. Ann Intern Med 1995; 122: 161-8.
20. Jarvis LM, Watson HG, McOmish F, Peutherer JF, Ludlum CA, Simmonds P. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused haemophiliacs. J Infect Dis 1994; 170: 1018-22.
21. Chan SW, McOmish F, Holmes EC, Dow BC, Peutherer JF, Follet E, et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131-41.
22. McOmish F, Yap PL, Dow BC, Follet EAC, Seed C, Keller AJ, et al. Geographical distribution of different hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 884-92.
23. Simmonds P, Holmes EC, Cha TA, Chan S-W, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-9.
24. Kew M, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984; 4: 136-45.
25. Melia W, Wilkinson M, Portmann B, Johnson PJ, Williams R. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis. Q J Med 1984; 211: 391-400.
26. Castells L, Vargas V, Gonzalez A, Esteban J, Esteban R, Guardia J. Long interval between HCV infection and development of hepatocellular carcinoma. Liver 1995; 15: 159-63.
27. De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, et al. HCV associated liver cancer without cirrhosis. Lancet 1995; 345: 413-5.
28. Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis B virus integration in a cylin A gene in a hepatocellular carcinoma. Nature 1990; 343: 555-7.
29. Dejean A, Bougueleret L, Grzeschik KH, Tiollais P. Hepatitis B virus DNA integration in a sequence homologous to v-erbA and steroid receptor genes in a hepatocellular carcinoma. Nature 1986; 322: 70-2.
30. Feitelson M. Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev 1992; 5: 275-301.
31. Paterlini P, Gerken G, Nakajima, Terre S, D'Errico A, Grigoni W, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323: 80-5.
32. Paterlini P, Poussin K, D'Errico A. Rate of persistence, structure and expression of HBV genome developing in HBsAg negative patients. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis and liver diseases. Tokyo: Springer-Verlag (in press).
33. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YHW. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH7 cells. J Virol 1993; 67: 5823-32.
34. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529-33.
35. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1088-96.
36. Yoshioka K, Kakuma S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-9.
37. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographical origin and disease. Virol Hepatitis Liver Disease 1994; 5: 301-5.